Differential inhibition of murine Bcrp1/Abcg2 and human BCRP/ABCG2 by the mycotoxin fumitremorgin C

This publication has 36 references indexed in Scilit:

• Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer
  Lung Cancer, 2010
• Identification and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3)
  International Journal of Pharmaceutics, 2010
• Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell Lines
  Cancer Research, 2009
• Histone Deacetylase Inhibitors Induce a Very Broad, Pleiotropic Anticancer Drug Resistance Phenotype in Acute Myeloid Leukemia Cells by Modulation of Multiple ABC Transporter Genes
  Clinical Cancer Research, 2009
• Vandetanib (Zactima, ZD6474) Antagonizes ABCC1- and ABCG2-Mediated Multidrug Resistance by Inhibition of Their Transport Function
  PLOS ONE, 2009
• ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate
  Cell Cycle, 2009
• Substrate-Dependent Breast Cancer Resistance Protein (Bcrp1/Abcg2)-Mediated Interactions: Consideration of Multiple Binding Sites in in Vitro Assay Design
  Drug Metabolism and Disposition, 2009
• Physiological and pharmacological roles of ABCG2 (BCRP): Recent findings in Abcg2 knockout mice
  Advanced Drug Delivery Reviews, 2009
• Porphyrin Homeostasis Maintained by ABCG2 Regulates Self-Renewal of Embryonic Stem Cells
  PLOS ONE, 2008
• Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter
  British Journal of Pharmacology, 2006